Overview
Michael Blumer practices practicing medicine in Bern, Switzerland.
His clinical expertise encompasses Chemosis, Wallerian Degeneration, Calcinosis, and Retinal Detachment.
He is actively involved in clinical research, co-authoring 55 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Michael F. Blumer
Is Michael F. Blumer a top-rated expert for Chemosis?
MediFind is an objective health platform that identifies experts based on real-world data. Michael F. Blumer is classified as an Experienced expert for Chemosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Michael F. Blumer participate in research or clinical trials?
Yes. Michael F. Blumer has published 55 articles and abstracts on conditions like Chemosis. You can view a list of Michael F. Blumer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- CalcinosisMr. Blumer isExperienced. Learn about Calcinosis.
- ChemosisMr. Blumer isExperienced. Learn about Chemosis.
- Retinal DetachmentMr. Blumer isExperienced. Learn about Retinal Detachment.
- Wallerian DegenerationMr. Blumer isExperienced. Learn about Wallerian Degeneration.